2024-09-01 2025-08-31 false No description of principal activity Capium Accounts Production 1.1 08163816 2024-09-01 2025-08-31 08163816 bus:AbridgedAccounts 2024-09-01 2025-08-31 08163816 bus:Micro-entities 2024-09-01 2025-08-31 08163816 bus:AuditExempt-NoAccountantsReport 2024-09-01 2025-08-31 08163816 bus:SmallCompaniesRegimeForAccounts 2024-09-01 2025-08-31 08163816 bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 08163816 2024-09-01 2025-08-31 08163816 2025-08-31 08163816 bus:RegisteredOffice 2024-09-01 2025-08-31 08163816 core:WithinOneYear 2025-08-31 08163816 core:AfterOneYear 2025-08-31 08163816 1 2024-09-01 2025-08-31 08163816 bus:Director1 2024-09-01 2025-08-31 08163816 bus:Director1 2025-08-31 08163816 bus:Director1 2023-09-01 2024-08-31 08163816 2023-09-01 08163816 bus:LeadAgentIfApplicable 2024-09-01 2025-08-31 08163816 2023-09-01 2024-08-31 08163816 2024-08-31 08163816 core:WithinOneYear 2024-08-31 08163816 core:AfterOneYear 2024-08-31 08163816 bus:EntityAccountantsOrAuditors 2023-09-01 2024-08-31 08163816 bus:OrdinaryShareClass1 2024-09-01 2025-08-31 08163816 bus:OrdinaryShareClass1 2025-08-31 08163816 bus:OrdinaryShareClass1 2023-09-01 2024-08-31 08163816 bus:OrdinaryShareClass1 2024-08-31 08163816 core:ComputerEquipment 2024-09-01 2025-08-31 08163816 core:ComputerEquipment 2025-08-31 08163816 core:ComputerEquipment 2024-08-31 08163816 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-08-31 08163816 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-08-31 08163816 core:CostValuation core:Non-currentFinancialInstruments 2025-08-31 08163816 core:CostValuation core:Non-currentFinancialInstruments 2024-08-31 08163816 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-08-31 08163816 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-08-31 08163816 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-08-31 08163816 core:Non-currentFinancialInstruments 2025-08-31 08163816 core:Non-currentFinancialInstruments 2024-08-31 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 08163816
England and Wales
DW MEDICOLEGAL SERVICES LIMITED
Abridged Accounts
Period of accounts Start date: 01 September 2024 End date: 31 August 2025

DW Medicolegal Services Limited Contents Page For the year ended 31 August 2025
Statement of financial position | 1

DW Medicolegal Services Limited Statement of Financial Position As at 31 August 2025
|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ | £ |  | £ | £
Current assets |  | 51,762 |  |  | 56,889 |
Creditors: amount falling due within one year |  | (3,324) |  |  | (2,701) |
Net current assets |  |  | 48,438 |  |  | 54,188
Total assets less current liabilities |  |  | 48,438 |  |  | 54,188
Net assets |  |  | 48,438 |  |  | 54,188
Capital and reserves |  |  | 48,438 |  |  | 54,188
NOTES TO THE ACCOUNTS General Information DW Medicolegal Services Limited is a private company, limited by shares, registered in England and Wales, registration number 08163816, registration address 34 Ryhill Way, Lower Early, Reading, RG6 4AZ. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies Statement of compliance These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. Basis of preparation The financial statements have been prepared under the historical cost convention. The financial statements are prepared in sterling which is the functional currency of the company. Going concern basis The directors believe that the company is experiencing good levels of sales growth and profitability, and that it is well placed to manage its business risks successfully. Accordingly, they have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the financial statements. Turnover Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts. Tangible fixed assets Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Computer Equipment | 20% Straight Line
2. | Tangible fixed assets
Cost or valuation | Computer Equipment |  | Total
| £ |  | £
At 01 September 2024 | 1,210 |  | 1,210
Additions | - |  | -
Disposals | - |  | -
At 31 August 2025 | 1,210 |  | 1,210
Depreciation
At 01 September 2024 | 1,210 |  | 1,210
Charge for year | - |  | -
On disposals | - |  | -
At 31 August 2025 | 1,210 |  | 1,210
Net book values
Closing balance as at 31 August 2025 | - |  | -
Opening balance as at 01 September 2024 | - |  | -
3. | Average number of employees Average number of employees during the year was 1 (2024 : 1).
For the year ended 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Director's Responsibilities: The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies. The members have agreed to the preparation of abridged accounts. The financial statements were approved by the director on 23 April 2026 and were signed by:
-------------------------------- Dr. Dumindu Witharana Director
1